Onchilles Pharma, Inc. — Form D

Onchilles Pharma, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-13. The offering totals $7.7M, of which $3.6M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2020-07-13
• Form: D
• Accession: 0001817759-20-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $7.7M
• Amount sold: $3.6M
• Remaining: $4.1M
• Investors: 10
• Date of first sale: 2020-06-30
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-370851

Issuer

• Name: Onchilles Pharma, Inc.
• CIK: 0001817759
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 4401 EASTGATE MALL, SAN DIEGO, CA, 92121
• Phone: 858-550-6000

Officers, directors & promoters (4)

More

• CIK 1817759 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search